Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder

Clinical trial NCT02557971 · COMPLETED

Trial details

NCT number: NCT02557971
Sponsor: Allergan
Status: COMPLETED
Study type: OBSERVATIONAL

Urinary Bladder, Overactive

Start date: 2015-08-01
Primary completion: 2016-07-01
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.